A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression.
Lapierre YD, Silverstone P, Reesal RT, Saxena B, Turner P, Bakish D, Plamondon J, Vincent PM, Remick RA, Kroft C, Payeur R, Rosales D, Lam R, Bologa M.
Lapierre YD, et al. Among authors: payeur r.
J Clin Psychopharmacol. 1998 Aug;18(4):268-73. doi: 10.1097/00004714-199808000-00002.
J Clin Psychopharmacol. 1998.
PMID: 9690691
Clinical Trial.